Given the critical role of glucose metabolism disorders in AP, we focused on PFKFB3, a key glycolytic regulatory enzyme whose activity is closely linked to various metabolic and inflammatory diseases (Xie et al. 2025; Zeng et al. 2022; Min et al. 2021; Kasprzak 2021). The gene discussed is PFKFB3; the disease is glucose metabolism disease.